Abstract: Systems herein allow a customer to provision an enterprise mobility management system (“EMM”) in a cloud service. A provisioning server can provide a portal for the customer to input an indication of a number of computing devices that the EMM system will service. The customer can also specify an EMM application version. Based on this information, the provisioning server can determine how many servers to instantiate in the cloud service and install the appropriate EMM application. The provisioning server can also monitor the number of devices and automatically instantiate additional servers as needed.

Abstract: Systems herein allow a customer to provision an enterprise mobility management system (“EMM”) in a cloud service. A provisioning server can provide a portal for the customer to input an indication of a number of computing devices that the EMM system will service. The customer can also specify an EMM application version. Based on this information, the provisioning server can determine how many servers to instantiate in the cloud service and install the appropriate EMM application. The provisioning server can also monitor the number of devices and automatically instantiate additional servers as needed.

Abstract: Systems herein allow a customer to provision an enterprise mobility management system (“EMM”) in a cloud service. A provisioning server can provide a portal for the customer to input an indication of a number of computing devices that the EMM system will service. The customer can also specify an EMM application version. Based on this information, the provisioning server can determine how many servers to instantiate in the cloud service and install the appropriate EMM application. The provisioning server can also monitor the number of devices and automatically instantiate additional servers as needed.

Abstract: A subsea oil over water storage tank, having one or multiple of high dynamic range, gas-liquid separators, which first receive oil well fluids, and cyclically depressurize and release free and solution gas to surface, and then expel unseparated liquids to the subsea storage tank, where the oil and water may be further separated by gravity separation, providing a means of separating stabilising crude oil.

Abstract: The invention relates to floating offshore facilities, columnar in form, often referred to as spars comprising a body having an upper column, a main compartment and a lower leg joined together to define the spar, wherein the spar further comprises an articulation for connecting an end of the lower leg to the seabed, wherein the lower leg geometry has been configured as having a particular geometry that in combination with a particular residual buoyancy of the spar, and for any particular geometry of the upper column and main compartment and in any specific water depth, the spar provides a particular dynamic response to wind, wave and forces applied by sea currents. The invention also relates to methods for varying the dynamic response to wind, wave and forces applied by sea currents of the spar and to methods for transferring materials and personnel between a production facility such as the spar and at least one transportation apparatus such as a dynamically positioned vessel.

Abstract: Systems herein allow a customer to provision an enterprise mobility management system (“EMM”) in a cloud service. A provisioning server can provide a portal for the customer to input an indication of a number of computing devices that the EMM system will service. The customer can also specify an EMM application version. Based on this information, the provisioning server can determine how many servers to instantiate in the cloud service and install the appropriate EMM application. The provisioning server can also monitor the number of devices and automatically instantiate additional servers as needed.

Abstract: A vessel generally in the form of a tanker or tank barge, the vessel having means for dynamically positioning thereof, to allow the vessel to approach an offshore facility, and deploy a gangway to it, allowing crew to transfer onto the facility, thereby making crew available to a normally unmanned facility. There is also provided a vessel comprising a hull having a bottom section adapted to be received by the surface of a body of water, the bottom section comprising at least one first and second helical propellers, the first helical propellers located adjacent the bow of hull and the second helical propellers located adjacent the stern of the hull. Moreover, there is provided a hose spooling device wherein the device is adapted to be connected to the facility for loading or unloading of hydrocarbons through paying out a hose over or near to the bow of the vessel.

Abstract: A vessel generally in the form of a tanker or tank barge, the vessel having means for dynamically positioning thereof, to allow the vessel to approach an offshore facility, and deploy a gangway to it, allowing crew to transfer onto the facility, thereby making crew available to a normally unmanned facility. There is also provided a vessel comprising a hull having a bottom section adapted to be received by the surface of a body of water, the bottom section comprising at least one first and second helical propellers, the first helical propellers located adjacent the bow of hull and the second helical propellers located adjacent the stern of the hull. Moreover, there is provided a hose spooling device wherein the device is adapted to be connected to the facility for loading or unloading of hydrocarbons through paying out a hose over or near to the bow of the vessel.

Abstract: A tank for storage of hydrocarbon liquids on the seabed, being of double hull construction which is compartmented to form a plurality of chambers, such that the tank may be safely towed from its build location or shipyard, to offshore deployment location as marine warranty compliant vessel, having appropriate intact and damaged stability characteristics. There is also provided a method for deploying a tank for storage of hydrocarbon liquids on the seabed, the method comprising the step of towing the tank having un-ballasted storage areas and compartments to the location of deployment; flooding at least partially the storage area to achieve substantial neutral buoyancy of the tank to allow decent of the tank up to a submerged equilibrium; allowing decent of the tank to the seabed and injecting air into at least one compartment for maintaining equilibrium between the pressure applied by the surrounding sea and the pressure inside compartments and storage area.

Abstract: The invention relates to a method of treating sialorrhea in a human patient, which comprises orally administering glycopyrrolate in a liquid solution to the human patient under fasted conditions.

Abstract: The invention relates to a method of increasing the bioavailability of glycopyrrolate by administration of a therapeutically effective amount of glycopyrrolate without food. The invention also provides a kit comprising a pharmaceutical composition comprising a therapeutically effective amount of glycopyrrolate and a pharmaceutically acceptable carrier, prescribing information including advice regarding the administration of glycopyrrolate without food to improve bioavailability, and a container.

Abstract: Kits providing a combination of one or more pharmaceutical information comprising one or more agent(s) for the treatment or alleviation of symptoms commonly associated with a cold and an immunonutritional composition comprising immunonutritional agent and methods of using these kits are described. The kits provide both the pharmaceutical agent(s) and the immunonutritional agent in a convenient form for administration. The kit typically includes instruction for coordinating the administration of the pharmaceutical formulation with the administration of the immunonutritional composition. The preferred immunonutritional agents are compounds that contain a pharmaceutically acceptable form of zinc, such as zinc acetate, zinc gluconate, zinc gluconate glycine, and zinc sulfate. Preferably the kit contains multiple dosage forms containing the immunonutritional composition. In the most preferred embodiment, the immunonutritional composition is in the form of a lozenge.

Abstract: Kits providing a combination of one or more pharmaceutical information comprising one or more agent(s) for the treatment or alleviation of symptoms commonly associated with a cold and an immunonutritional composition comprising immunonutritional agent and methods of using these kits are described . The kits provide both the pharmaceutical agent(s) and the immunonutritional agent in a convenient form for administration. The kit typically includes instruction for coordinating the administration of the pharmaceutical formulation with the administration of the immunonutritional composition. The preferred immunonutritional agents are compounds that contain a pharmaceutically acceptable form of zinc, such as zinc acetate, zinc gluconate, zinc gluconate glycine, and zinc sulfate. Preferably the kit contains multiple dosage forms containing the immunonutritional composition. In the most preferred embodiment, the immunonutritional composition is in the form of a lozenge.

Abstract: Apparatus for reducing dust emissions from particulate commodities such as wheat or coal using a curved loading spoon connected to the discharge from a loading spout. The curved loading spoon turns particulate commodities delivered at a rate above a predetermined delivery velocity against a curved outer wall causing dust arising from the particulate commodities to be re-entrained within the commodities as they are diverted from a straight path by the curvature. Also described are an optional flap designed to rest just above the surface of the commodities stream adjacent the outlet, and a converging duct located upstream of the curve loading spoon and arranged to direct commodities against the curved outer wall adjacent the inlet.

Abstract: A heating apparatus is provided for use during a welding operation on a component. In one embodiment, the apparatus includes a die having a cavity having at least a portion shaped to complement a first portion of the component and an opening providing a space through which a second portion of the component extends. A primary heating element is embedded in the die and generates heat upon being energized. A die temperature sensor is embedded in the die proximate the primary heating element and senses primary heating element temperature and supplies a temperature signal representative thereof. A component temperature sensor is embedded in the die, and senses a temperature of the component in the cavity and supplies a temperature signal representative thereof. A controller couples to receive the temperature signals and is operable, in response thereto, to selectively energize and de-energize the primary heating element.

Abstract: Compositions and methods for the treatment of osteoporosis and/or inflammatory joint disease are provided herein. The compositions contain a folate, such as a reduced folate, and folic acid. The folate is preferably 5-methyltetrahydrofolate, and most preferably 5-methyl-(6S)-tetrahydrofolic acid. The folate and folic acid can be given in the same dosage unit or separate dosage units, and more than one dosage unit can be given per dose. The compositions may also contain one or more vitamins and minerals selected from vitamin B12, vitamin B6, vitamin D3, calcium, magnesium, and polyunsaturated fatty acids (PUFAs). These ingredients are optional, but preferable (especially the vitamins and minerals). The compositions may further contain one or more additional ingredients such as vitamins, minerals, and laxatives.

Abstract: Compositions and methods for improving the nutritional and physiological status of a woman and her child during all stages of pregnancy are provided herein. This includes pre-conceptional women, pregnant women, and post-natal women (both lactating and non-lactating mothers). The compositions are particularly useful for the neurological, visual, and cognitive development of an embryo, fetus, or infant and the nutritional and physiological well-being of the mother, fetus, and infant. The compositions contain one or more folates, such as a reduced folate and/or folic acid, and one or more essential fatty acids (EFA), such as an omega-3 and/or omega-6 fatty acid. The addition of the essential fatty acid improves upon the folate containing nutritional preparations described in the prior art. The one or more folates and essential fatty acid may be administered together or in separate dosage units.

Abstract: Compositions and methods for improving the nutritional and physiological status of a woman and her child during all stages of pregnancy are provided herein. This includes pre-conceptional women, pregnant women, and post-natal women (both lactating and non-lactating mothers). The compositions are particularly useful for the neurological, visual, and cognitive development of an embryo, fetus, or infant and the nutritional and physiological well-being of the mother, fetus, and infant. The compositions contain one or more folates, such as a reduced folate and/or folic acid, and one or more essential fatty acids (EFA), such as an omega-3 and/or omega-6 fatty acid. The addition of the essential fatty acid improves upon the folate containing nutritional preparations described in the prior art. The one or more folates and essential fatty acid may be administered together or in separate dosage units.

Abstract: A nutraceutical composition and method of use thereof includes core ingredients, huperzine A, dimethylaminoethanol (DMAE), thiamin, niacin, and pantothenic acid. The core ingredients provide a synergistic effect to improve and support cognitive function, such as learning, thinking, and judging and to promote alertness, awareness, attention and mental clarity. Combinations of additional ingredients, such as vinpocetine, acetyl-L-carnitine, L-pyroglutamic acid, pyridoxine, folic acid, vitamin B12, phosphatidylserine, L-theanine, and rhodiola rosea can be added to the core ingredients to enhance the beneficial and synergistic effects of the composition.

Abstract: The invention relates to a method of increasing the bioavailability of glycopyrrolate by administration of a therapeutically effective amount of glycopyrrolate without food.